Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024

Publisher Name :
Date: 12-Jul-2018
No. of pages: 224

The global influenza vaccines market is anticipated to exceed US$ 5.8 Billion mark by 2024, and is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, introduction of new vaccines, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will drive the influenza vaccines market. However, shortage of vaccine supply due to genetic assortment of the viral strains is surging the need for updating vaccines each year by the manufacturers.  This is a major factor restraining market growth.  

Global Influenza Vaccines Market – Regional Analysis


  • Geographically, North America is the largest market for influenza vaccines capturing over 48% market share in 2017.

  • Asia is the second largest market for influenza vaccines.

  • Europe is the third largest market for influenza vaccines, followed by Latin America.

  • Australasia accounted for least share of the influenza vaccines market in 2017.


Global Influenza Vaccines Market – Country Wise Analysis


  • On the basis of country, United States captures majority of the influenza vaccines market.

  • Japan is the second largest market for influenza vaccines.

  • China, Brazil and India are the third, fourth and fifth leading market for influenza vaccines respectively.

  • Canada, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza vaccines.


Global Influenza Vaccines Market – Brands Analysis


  • In the influenza vaccines brand sales segment, Sanofi’s Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax.

  • In May 2016, the cell-based Flucelvax quadrivalent shot was approved by the FDA.

  • GSK’s Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market.

  • Fluad is the first and only adjuvanted seasonal influenza vaccine in the US for adults aged 65 and older.

  • Flublok has captured least share of the influenza vaccines market.

  • In October 2016, Protein Sciences received approval from the FDA for the quadrivalent version of Flublok vaccine.

  • On August 28, 2017 - Sanofi announced that it has completed the acquisition of Protein Sciences.

  • In February 2018, SK Chemicals Co. signed a US$ 155 Million deal to license cell culture technology to Sanofi Pasteur Inc. for development of a universal influenza vaccine.


This is the 4th edition report on influenza vaccines market by iGATE Research. The report titled “Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024” provides a comprehensive assessment of the fast-evolving, high-growth influenza vaccines market landscape.

This 224 Page report with 139 Figures and 12 Tables has been analyzed from 5 viewpoints:


  • Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2024)

  • Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2024)

  • Global - Influenza Vaccines Brand Sales and Forecast to 2024

  • Global Influenza Vaccines Market - Major Deals

  • Global Influenza Vaccines Market - Driving Factors and Challenges


Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region


  • North America

  • Latin America

  • Europe

  • Asia

  • Australasia


Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (25 Countries Covered)


  • United States

  • Canada

  • Brazil

  • Mexico

  • Germany

  • France

  • Italy

  • Spain

  • United Kingdom

  • Netherlands

  • Ireland

  • Denmark

  • Luxembourg

  • Sweden

  • Australia

  • New Zealand

  • Japan

  • China

  • India

  • South Korea

  • Singapore

  • Hong Kong

  • Malaysia

  • Thailand

  • Indonesia


Influenza Vaccines Brand Sales and Forecast - 8 Brands Analyzed


  • 1. Fluarix/FluLaval

  • 2. Fluzone

  • 3. Fluvirin/Flucelvax

  • 4. Influvac

  • 5. Afluria/Fluvax

  • 6. FluMist/Fluenz

  • 7. Flublok

  • 8. Fluad


Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024

Table of Contents

1. Executive Summary

2. Global - Influenza Vaccines Market Analysis and Forecast (2011 - 2024)
2.1 Global - Influenza Vaccines Market and Forecast (2011 - 2024)
2.2 Global - Number of Persons Vaccinated with Influenza Vaccines and Forecast (2011 - 2024)

3. Global - Influenza Vaccines Market Share Analysis and Forecast
3.1 Influenza Vaccines Market Share and Forecast - Region Wise Analysis (2011 - 2024)
3.2 Influenza Vaccines Market Share and Forecast - Country Wise Analysis (2011 - 2024)
3.3 Persons Being Vaccinated with Influenza Vaccines Share and Forecast - Region Wise Analysis (2011 - 2024)
3.4 Persons Being Vaccinated with Influenza Vaccines Share and Forecast - Country Wise Analysis (2011 - 2024)

4. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2024)
4.1 North America - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.1.1 North America - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.1.2 North America - Influenza Vaccines Market and Forecast
4.2 Latin America - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.2.1 Latin America - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.2.2 Latin America - Influenza Vaccines Market and Forecast
4.3 Europe - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.3.1 Europe - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.3.2 Europe - Influenza Vaccines Market and Forecast
4.4 Asia - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.4.1 Asia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.4.2 Asia - Influenza Vaccines Market and Forecast
4.5 Australasia - Influenza Vaccines Market, Persons Vaccinated and Forecast
4.5.1 Australasia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
4.5.2 Australasia - Influenza Vaccines Market and Forecast

5. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2024)
5.1 United States - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.1.1 United States - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.1.2 United States - Influenza Vaccines Market and Forecast
5.2 Canada - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.2.1 Canada - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.2.2 Canada - Influenza Vaccines Market and Forecast
5.3 Brazil - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.3.1 Brazil - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.3.2 Brazil - Influenza Vaccines Market and Forecast
5.4 Mexico - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.4.1 Mexico - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.4.2 Mexico - Influenza Vaccines Market and Forecast
5.5 Germany - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.5.1 Germany - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.5.2 Germany - Influenza Vaccines Market and Forecast
5.6 France - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.6.1 France - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.6.2 France - Influenza Vaccines Market and Forecast
5.7 Italy - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.7.1 Italy - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.7.2 Italy - Influenza Vaccines Market and Forecast
5.8 Spain - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.8.1 Spain - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.8.2 Spain - Influenza Vaccines Market and Forecast
5.9 United Kingdom - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.9.1 United Kingdom - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.9.2 United Kingdom - Influenza Vaccines Market and Forecast
5.10 Netherlands - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.10.1 Netherlands - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.10.2 Netherlands - Influenza Vaccines Market and Forecast
5.11 Ireland - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.11.1 Ireland - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.11.2 Ireland - Influenza Vaccines Market and Forecast
5.12 Denmark - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.12.1 Denmark - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.12.2 Denmark - Influenza Vaccines Market and Forecast
5.13 Luxembourg - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.13.1 Luxembourg - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.13.2 Luxembourg - Influenza Vaccines Market and Forecast
5.14 Sweden - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.14.1 Sweden - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.14.2 Sweden - Influenza Vaccines Market and Forecast
5.15 Australia - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.15.1 Australia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.15.2 Australia - Influenza Vaccines Market and Forecast
5.16 New Zealand - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.16.1 New Zealand - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.16.2 New Zealand - Influenza Vaccines Market and Forecast
5.17 Japan - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.17.1 Japan - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.17.2 Japan - Influenza Vaccines Market and Forecast
5.18 China - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.18.1 China - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.18.2 China - Influenza Vaccines Market and Forecast
5.19 India - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.19.1 India - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.19.2 India - Influenza Vaccines Market and Forecast
5.20 South Korea - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.20.1 South Korea - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.20.2 South Korea - Influenza Vaccines Market and Forecast
5.21 Thailand - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.21.1 Thailand - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.21.2 Thailand - Influenza Vaccines Market and Forecast
5.22 Singapore - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.22.1 Singapore - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.22.2 Singapore - Influenza Vaccines Market and Forecast
5.23 Hong Kong - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.23.1 Hong Kong - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.23.2 Hong Kong - Influenza Vaccines Market and Forecast
5.24 Malaysia - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.24.1 Malaysia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.24.2 Malaysia - Influenza Vaccines Market and Forecast
5.25 Indonesia - Influenza Vaccines Market, Persons Vaccinated and Forecast
5.25.1 Indonesia - Number of Persons Vaccinated with Influenza Vaccines and Forecast
5.25.2 Indonesia - Influenza Vaccines Market and Forecast

6. Global - Influenza Vaccines Brand Sales and Forecast
6.1 Global - Fluarix / FluLaval Sales and Forecast (2007 - 2024)
6.2 Global - Fluzone Sales and Forecast (2009 - 2024)
6.3 Global - Fluvirin/Flucelvax Sales and Forecast (2010 - 2024)
6.4 Global - Influvac (Acquired by Abbott) Sales (2007 - 2009)
6.5 Global - Afluria/Fluvax Sales and Forecast (2010 - 2024)
6.6 Global - FluMist/Fluenz Sales and Forecast (2007 - 2024)
6.7 Global - Flublok Sales and Forecast (2013 - 2024)
6.8 Global – Fluad Sales and Forecast (2016 - 2024)

7. Influenza Vaccines Market - Major Deals
7.1 Mergers and Acquisitions
7.2 Licensing Agreements

8. Global Influenza Vaccines Market - Driving Factors
8.1 Transformation of Vaccine Technologies
8.2 Vaccines most Cost-Effective Means of Disease Prevention
8.3 Scientific & Technological Breakthroughs
8.4 Continuous Focus on Effective Communication Strategies
8.5 Rising incidence of pandemic events Increasing Awareness on Seasonal Influenza & Vaccination

9. Global Influenza Vaccines Market - Challenges
9.1 Complexity of Vaccine Development and Approval System Thwarts Product Development
9.1.1 Legal Obstacles
9.1.2 General Technical Barriers
9.1.3 Economic Barriers
9.1.4 Regulatory Barriers
9.2 Hurdles to Optimal use of Licensed Vaccines
9.2.1 Technical Obstacles
9.2.2 Economic obstacles
9.2.3 Cultural Obstacles
9.3 Barriers to New Entrants in the Vaccines Market
9.4 Reducing the Timeline for Vaccine Development
9.5 Challenges Faced by Healthcare Workers in Immunization

List of Figures:

Figure 2-1: Global - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 2-2: Global - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 2-3: Global - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 2-4: Global - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 4-1: North America - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 4-2: North America - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 4-3: North America - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 4-4: North America - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 4-5: Latin America - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 4-6: Latin America - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 4-7: Latin America - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 4-8: Latin America - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 4-9: Europe - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 4-10: Europe - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 4-11: Europe - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 4-12: Europe - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 4-13: Asia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 4-14: Asia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 4-15: Asia - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 4-16: Asia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 4-17: Australasia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 4-18: Australasia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 4-19: Australasia - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 4-20: Australasia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-1: United States - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-2: United States - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-3: United States - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-4: United States - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-5: Canada - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-6: Canada - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-7: Canada - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-8: Canada - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-9: Brazil - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-10: Brazil - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-11: Brazil - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-12: Brazil - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-13: Mexico - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-14: Mexico - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-15: Mexico - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-16: Mexico - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-17: Germany - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-18: Germany - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-19: Germany - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-20: Germany - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-21: France - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-22: France - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-23: France - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-24: France - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-25: Italy - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-26: Italy - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-27: Italy - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-28: Italy - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-29: Spain - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-30: Spain - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-31: Spain - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-32: Spain - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-33: United Kingdom - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-34: United Kingdom - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-35: United Kingdom - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-36: United Kingdom - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-37: Netherlands - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-38: Netherlands - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-39: Netherlands - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-40: Netherlands - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-41: Ireland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-42: Ireland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-43: Ireland - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-44: Ireland - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-45: Denmark - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-46: Denmark - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-47: Denmark - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-48: Denmark - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-49: Luxembourg - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-50: Luxembourg - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-51: Luxembourg - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-52: Luxembourg - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-53: Sweden - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-54: Sweden - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-55: Sweden - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-56: Sweden - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-57: Australia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-58: Australia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-59: Australia - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-60: Australia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-61: New Zealand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-62: New Zealand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-63: New Zealand - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-64: New Zealand - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-65: Japan - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-66: Japan - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-67: Japan - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-68: Japan - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-69: China - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-70: China - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-71: China - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-72: China - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-73: India - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-74: India - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-75: India - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-76: India - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-77: South Korea - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-78: South Korea - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-79: South Korea - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-80: South Korea - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-81: Thailand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-82: Thailand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-83: Thailand - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-84: Thailand - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-85: Singapore - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-86: Singapore - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-87: Singapore - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-88: Singapore - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-89: Hong Kong - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 – 2017
Figure 5-90: Hong Kong - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-91: Hong Kong - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-92: Hong Kong - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-93: Malaysia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-94: Malaysia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-95: Malaysia - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-96: Malaysia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 5-97: Indonesia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
Figure 5-98: Indonesia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
Figure 5-99: Indonesia - Influenza Vaccines Market (Million US$), 2011 - 2017
Figure 5-100: Indonesia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
Figure 6-1: Global - Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2007 - 2017
Figure 6-2: Global - Forecast for Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2018 - 2024
Figure 6-3: Global - Fluzone Influenza Vaccine Sales (Million US$), 2009 - 2017
Figure 6-4: Global - Forecast for Fluzone Influenza Vaccine Sales (Million US$), 2018 - 2024
Figure 6-5: Global - Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2010 - 2017
Figure 6-6: Global - Forecast for Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2018 - 2024
Figure 6-7: Global - Influvac Influenza Vaccine Sales (Million US$), 2007 - 2009
Figure 6-8: Global - Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2010 - 2017
Figure 6-9: Global - Forecast for Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2018 - 2024
Figure 6-10: Global - FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2007 - 2017
Figure 6-11: Global - Forecast for FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2018 - 2024
Figure 6-12: Global - Flublok Influenza Vaccine Sales (Million US$), 2013 - 2017
Figure 6-13: Global - Forecast for Flublok Influenza Vaccine Sales (Million US$), 2018 - 2024
Figure 6-14: Global - Fluad Influenza Vaccine Sales (Million US$), 2016 - 2017
Figure 6-15: Global - Forecast for Fluad Influenza Vaccine Sales (Million US$), 2018 - 2024

List of Tables:

Table 3-1: Region Wise - Influenza Vaccines Market Share (Percent), 2011 - 2017
Table 3-2: Region Wise - Forecast for Influenza Vaccines Market Share (Percent), 2018 - 2024
Table 3-3: Country Wise - Influenza Vaccines Market Share (Percent), 2011 - 2017
Table 3-4: Country Wise - Forecast for Influenza Vaccines Market Share (Percent), 2018 - 2024
Table 3-5: Region Wise - Persons Vaccinated with Influenza Vaccines Share (Percent), 2011 - 2017
Table 3-6: Region Wise - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2018 - 2024
Table 3-7: Country Wise - Persons Vaccinated with Influenza Vaccines Share (Percent), 2011 - 2017
Table 3-8: Country Wise - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2018 - 2024
Table 7-1: Global - Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005 - 2017
Table 7-2: Global - Licensing Agreement in Influenza Vaccines Market (Million US$), 2007 - 2018
Table 8-1: Improvement Strategies or Requirements - the Joint Commission and the Project’s Collaborating Organizations
Table 8-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009

  • Global Encephalitis Vaccination Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 05-Sep-2018        Price: US 3480 Onwards        Pages: 132
    Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. People and many animals may be infection source after infection Encephalitis virus. Scope of the Report: This report studies the Encephalitis Vaccination market status and outlook ......
  • Global Influenza Vaccine Market Professional Survey Report 2018
    Published: 28-Aug-2018        Price: US 3500 Onwards        Pages: 117
    This report studies the global Influenza Vaccine market status and forecast, categorizes the global Influenza Vaccine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vacci......
  • 2018-2023 Global Encephalitis Vaccination Market Report (Status and Outlook)
    Published: 28-Aug-2018        Price: US 4660 Onwards        Pages: 119
    In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Encephalitis Vaccination market for 2018-2023. Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. Peopl......
  • Global H1N1 Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 27-Aug-2018        Price: US 3480 Onwards        Pages: 137
    A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Scope of the Report: This report focuses on the H1N1 Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. ......
  • Global and India Avian Influenza Vaccines Market Research by Company, Type & Application 2013-2025
    Published: 26-Aug-2018        Price: US 2000 Onwards        Pages: 113
    Summary Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred. Market Segment as follows: By Type - Type H5 - Type H9 - Others ......
  • Global H1N1 Vaccines Market Professional Survey Report 2018
    Published: 24-Aug-2018        Price: US 3500 Onwards        Pages: 106
    This report studies the global H1N1 Vaccines market status and forecast, categorizes the global H1N1 Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and......
  • Global Encephalitis Vaccine Market Professional Survey Report 2018
    Published: 17-Aug-2018        Price: US 3500 Onwards        Pages: 100
    This report studies the global Encephalitis Vaccine market status and forecast, categorizes the global Encephalitis Vaccine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoe......
  • Global and Chinese Pneumococcal Polysaccharide Vaccine Industry, 2018 Market Research Report
    Published: 14-Aug-2018        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Pneumococcal Polysaccharide Vaccine Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Pneumococcal Polysaccharide Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pneumococcal Polysaccharide Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report p......
  • China Influenza Vaccine Market Research Report 2018
    Published: 14-Aug-2018        Price: US 3400 Onwards        Pages: 124
    This report studies the Influenza Vaccine development status and future trend in China, focuses on top players in China, also splits Influenza Vaccine by type and by applications, to fully and deeply research and reveal the market general situation and future forecast. In the last several years, China market of Influenza Vaccine developed fluctuation, with an average growth rate of -9.03%. In 2017, China Revenue of Influenza Vaccine is nearly 75.13 M USD; the actual production is ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs